# ONC-201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant

> **NCT03932643** · PHASE1 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 20 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Myelodysplastic Syndromes

## Interventions

- **DRUG:** ONC-201

## Key facts

- **NCT ID:** NCT03932643
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-30
- **Primary completion:** 2025-03-27
- **Final completion:** 2025-03-27
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03932643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03932643, "ONC-201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03932643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*